Herbas VPB

Print
EN | LT
LT - ENDOGLIN-SPECIFIC ANTIBODY FOR USE IN A METHOD OF TREATING HEART FAILURE AND RELATED CONDITIONS
EN - ENDOGLIN-SPECIFIC ANTIBODY FOR USE IN A METHOD OF TREATING HEART FAILURE AND RELATED CONDITIONS

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 38/17
A61K 38/18
A61K 39/395
A61K 31/713
A61K 31/7088
C07K 16/28
A61P 9/00
A61P 9/04
A61P 43/00
C07K 16/22
European patent
(11) Number of the document 2739645
(13) Kind of document T
(96) European patent application number 12820719.8
Date of filing the European patent application 2012-07-31
(97) Date of publication of the European application 2014-06-11
(45) Date of publication and mention of the grant of the patent 2018-12-19
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/US2012/049018
Date 2012-07-31
PCT application publication
(87) Number WO 2013/019805
Date 2013-02-07
Priority applications
(30) Number Date Country code
201161513930 P 2011-08-01 US
201161578477 P 2011-12-21 US
Inventors
(72)
KAPUR, Navin, K., US
KARAS, Richard, H., US
Grantee
(73) Tufts Medical Center, Inc., 750 Washington Street, Boston, MA 02111, US
Title
(54) ENDOGLIN-SPECIFIC ANTIBODY FOR USE IN A METHOD OF TREATING HEART FAILURE AND RELATED CONDITIONS
  ENDOGLIN-SPECIFIC ANTIBODY FOR USE IN A METHOD OF TREATING HEART FAILURE AND RELATED CONDITIONS
Last update date 2021-04-30